Melda Meral Ocal (Melda Meral Öcal)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Acinetobacter Baumannii

Multidrug Resistant

Molecular Dynamics

Top Venues

Pathogens and disease

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mümtaz Güran, Kadir Çakıral, Kerem Terali, Tülay Kandemir, Gizem Şanlıtürk, Melda Meral Ocal, Togrul Nagiyev, Fatih Köksal
Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitro. Pathogens and disease 81 (2023)
Debora Brito Goulart, Ashenafi Feyisa Beyi, Zuowei Wu, Mehmet Cemal Adiguzel, Anastasia Schroeder, Kritika Singh, Changyun Xu, Melda Meral Ocal, Renee Dewell, Grant A Dewell, Paul Joseph Plummer, Qijing Zhang, Orhan Sahin
Effect of Danofloxacin Treatment on the Development of Fluoroquinolone Resistance in Campylobacter jejuni in Calves. Antibiotics (Basel, Switzerland) 11 (4) (2022)
Zuowei Wu, Michael J Yaeger, Orhan Sahin, Changyun Xu, Ashenafi F Beyi, Paul J Plummer, Melda Meral Ocal, Qijing Zhang
A Homologous Bacterin Protects Sheep against Abortion Induced by a Hypervirulent Campylobacter jejuni Clone. Vaccines 8 (4) (2020)